FDA Inspection 1122926 — Karyopharm Therapeutics Inc.
The FDA completed an inspection of Karyopharm Therapeutics Inc. on February 28, 2020 in Newton, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 28, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Newton, MA (United States)
Additional Details
Sponsor, Contract Research Organization